Securities and Exchange Commission Archives | Be Korea-savvy
GT Advanced Technologies Concludes Matter with the SEC

GT Advanced Technologies Concludes Matter with the SEC

HUDSON, N.H., May 3 (Korea Bizwire) — GT Advanced Technologies Inc., the parent of GTAT Corporation (collectively, “Company”), has entered into a settlement agreement with the Securities and Exchange Commission (“SEC”) relating to an investigation into events leading up to the Company’s bankruptcy filing in 2014.  The Company welcomes the conclusion of this matter which [...]

Dubuc Motors Receives SEC Qualification Under US JOBS Act

Dubuc Motors Receives SEC Qualification Under US JOBS Act

MENLO PARK, Calif., Feb. 23 (Korea Bizwire) — Dubuc Motors, the company behind the Tomahawk – the world’s first 2+2 electric sports car, announced today the launch of the live offering phase of its equity crowdfunding campaign after the qualification of its filing with the Securities and Exchange Commission (SEC). The company revealed its electric [...]

RedHill Biopharma Announces Closing of Concurrent Public Offering and Registered Direct Offering of its American Depositary Shares and Warrants and Partial Exercise of the Option of Underwriters

RedHill Biopharma Announces Closing of Concurrent Public Offering and Registered Direct Offering of its American Depositary Shares and Warrants and Partial Exercise of the Option of Underwriters

TEL-AVIV, Israel, Dec. 27 (Korea Bizwire) — RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” or the “Company”), a biopharmaceutical company primarily focused on the development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for gastrointestinal and inflammatory diseases and cancer, today announced the closing of its previously announced underwritten public offering and its concurrent [...]

RedHill Biopharma Announces Proposed Concurrent Public Offering and Registered Direct Offering of its American Depositary Shares and Warrants

RedHill Biopharma Announces Proposed Concurrent Public Offering and Registered Direct Offering of its American Depositary Shares and Warrants

TEL-AVIV, Israel, Dec. 20 (Korea Bizwire) — RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” or the “Company”), a biopharmaceutical company primarily focused on the development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for gastrointestinal and inflammatory diseases and cancer, today announced that it intends to offer its American Depositary Shares (“ADSs”), each representing [...]